TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
MCRB

Seres Therapeutics Inc

Healthcare · Biotechnology

4.10$ +1.8% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

Seres Therapeutics Inc (MCRB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 1.1 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow MCRB
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-10 -41 44 -76 -63 -77 -94 6.7 -229 -117 -149 1.1
0.2 0.7 4.2 7.3 7.9 7.6 6.6 5.9 6.6 6.2 5.5 4.1
2.1 9.7 17 17 17 8.3 8.8 20 25 34 21 11
3.9 10 17 17 17 8.7 8.8 24 25
2.3 3.1 115 -11 12 -25 -23 42 -18 -59 -66 -28
1.0 4.4 21 4.7 1.9 1.0 0.6 9.6 9.8 8.0 0.4 0.3
-1.1 -137 -65 57 112 -31 -159 64 82 11 142 0.0
0.3 0.0 0.0
0.0 0.0 2.1 0.0 -0.2 61 259 2.1 99
1.6 -2.6 25 25 25 25 -0.9 -0.9 26 51 -128 0.0
124 138 2.1 0.1 0.3 86 303 1.2 130 72 -90 14
113 -40 -19 -18 50 -21 51 72 -17 -35 -97 15
-11 -45 22 -80 -65 -78 -94 -2.9 -239 -125 -149 0.9

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?